Stanley Riddell
Member at Fred Hutchinson Cancer Research Center.
Dr. Stan Riddell is a world leader in developing immunotherapies, which harness the power of the immune system to fight cancers and dangerous infections. His research focuses on detailing the complex biology of immune cells called T cells and pioneering therapies that use genetically reprogrammed T cells to specifically recognize and destroy diseased cells. These therapeutic T cells zero in on specific protein targets known as antigens, using either natural molecules called T-cell receptors or synthetic molecules called chimeric antigen receptors. Chimeric antigen receptors, also known as CARs, combine elements from T-cell receptors and from other immune cell-produced antibody molecules. His team’s breakthroughs are helping researchers make progress for patients who need better therapies.
Visit website: http://research.fhcrc.org/riddell/en.html%20
See also: Fred Hutchinson Cancer Research Center - Cancer Research Center for the elimination of cancer and related diseases
Details last updated 28-Jul-2020
Stanley Riddell News
Modified white blood cell cancer treatment has unprecedented success
BBC - 16-Feb-2016
90% of terminally ill patients treated went into remission. Leukaemia patients’ own white blood ...
Read more...